Danaher Corporation DHR has been benefiting from strength in its bioprocessing business, driven by an increase in demand for ...

Abcam plc, a leading supplier of life science research tools, has appointed Alan Hirzel as Chief Executive Officer with immediate effect to lead the company through its next stage of growth. He ...

Abcam plc recently announced the launch of its direct service to Singapore, as part of a global commitment to support local researchers’ needs. The new Singapore service will provide direct technical ...

Founded in Cambridge in 1998, biotech firm Abcam made a name for itself producing high-quality, validated antibodies for research. The company was listed on NASDAQ in 2020, and was eventually ...

If you’ve ever worked in a biotech lab, chances are you’ve benefited from his legacy. The founder of Abcam, Jonathan Milner, transformed the way scientists access antibodies. Under his leadership as ...

US company Danaher has begun life in control of Abcam in Cambridge by unveiling a new head honcho. Its $5.7 billion acquisition of Abcam was completed last December. Markus Lusser becomes President at ...

US group Danaher has completed its takeover of Abcam, a UK firm specialising in antibodies and life science consumables, for $5.7 billion (£4.5 billion) in cash. Abcam is now a wholly owned subsidiary ...

Abcam will join the likes of Beckman Coulter as a subsidiary of Danaher’s life sciences division. Photo: Sundry Photography / Shutterstock.com. Protein research tools supplier Abcam will almost ...

Though RSV is responsible for thousands of deaths and hospitalizations each year among young children and seniors, it’s defied scientists’ attempts to successfully develop a vaccine until now. The ...

Jonathan Milner, a leading UK breast cancer specialist who founded Cambridge-based biotech group Abcam in 1998, is aiming to thwart a US takeover bid. The company moved its share listing to the ...

CAMBRIDGE, England & WALTHAM, Mass.--(BUSINESS WIRE)--Abcam plc (Nasdaq: ABCM) (‘Abcam,’ the ‘Group’ or the ‘Company’), a global leader in the supply of ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Abcam has defended the handling of its proposed $5.7bn takeover by Danaher, insisting that the UK life ...